These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32847094)

  • 1. Searching for Promoters to Drive Stable and Long-Term Transgene Expression in Fibroblasts for Syngeneic Mouse Tumor Models.
    Antonova DV; Alekseenko IV; Siniushina AK; Kuzmich AI; Pleshkan VV
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possibility for Transcriptional Targeting of Cancer-Associated Fibroblasts-Limitations and Opportunities.
    Antonova DV; Zinovyeva MV; Kondratyeva LG; Sass AV; Alekseenko IV; Pleshkan VV
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
    Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
    Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
    Addison CL; Hitt M; Kunsken D; Graham FL
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
    Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
    Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.
    Ginn SL; Fleming J; Rowe PB; Alexander IE
    Hum Gene Ther; 2003 Aug; 14(12):1127-37. PubMed ID: 12908965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
    Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
    Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression.
    Yamada Y; Ishikawa T; Harashima H
    Biomaterials; 2017 Aug; 136():56-66. PubMed ID: 28521201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter.
    Duan B; Cheng L; Gao Y; Yin FX; Su GH; Shen QY; Liu K; Hu X; Liu X; Li GP
    Theriogenology; 2012 Sep; 78(4):793-802. PubMed ID: 22541322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential influence of the E4 adenoviral genes on viral and cellular promoters.
    Grave L; Dreyer D; Dieterle A; Leroy P; Michou AI; Doderer C; Pavirani A; Lusky M; Mehtali M
    J Gene Med; 2000; 2(6):433-43. PubMed ID: 11199264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene.
    Flasshove M; Bardenheuer W; Schneider A; Hirsch G; Bach P; Bury C; Moritz T; Seeber S; Opalka B
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):391-9. PubMed ID: 10929761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis.
    Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ
    Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy.
    Luo Y; Zhu D
    Biomed Res Int; 2014; 2014():751397. PubMed ID: 24864258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
    Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
    Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors.
    Armentano D; Smith MP; Sookdeo CC; Zabner J; Perricone MA; St George JA; Wadsworth SC; Gregory RJ
    J Virol; 1999 Aug; 73(8):7031-4. PubMed ID: 10400804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Tetracycline-regulated Promoters in Lentiviral-based Vectors in Murine Transplantation Studies.
    Stahlhut M; Ha TC; Morgan M; Schambach A; Kustikova OS
    Curr Gene Ther; 2016; 16(4):242-248. PubMed ID: 27739375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.